Raymond James Financial
ITOS

Raymond James Financial’s iTeos Therapeutics ITOS Stock Holding History

Raymond James Financial’s Portfolio ITOS Stock Details ITOS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-125
Closed -$1.25K – 5836
2025
Q2 		$1.25K Buy
+125
New +$1.01K ﹤0.01% 6520
2025
Q1 		– Sell
-150,967
Closed -$1.16M – 4885
2024
Q4 		$1.16M Buy
+150,967
New +$1.3M ﹤0.01% 3351

Other funds holding ITOS

IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

Raymond James Financial's ITOS Position: Q3 2025 in Review

Raymond James Financial sold out of iTeos Therapeutics (ITOS) in Q3 2025, closing a stake of 125 shares — an estimated $1.25K sold.

Raymond James Financial first reported a position in ITOS in Q4 2024 and held it in 2 quarters. The position peaked at $1.16M in Q4 2024. 1 fund tracked by Wall St. Rank holds ITOS as of Q3 2025.

  • Raymond James Financial reported no remaining iTeos Therapeutics position as of Q3 2025 after selling out during the quarter.
  • Raymond James Financial sold 125 iTeos Therapeutics shares in Q3 2025, an estimated $1.25K.
  • Raymond James Financial first reported a position in iTeos Therapeutics in Q4 2024 and held it in 2 quarters.
  • Raymond James Financial's iTeos Therapeutics position peaked at $1.16M in Q4 2024.
  • 1 fund tracked by Wall St. Rank held iTeos Therapeutics as of Q3 2025.

Based on Raymond James Financial's 13F filing for Q3 2025, filed 14 Nov 2025.